Zurich Cantonal Bank
COLL icon

Zurich Cantonal Bank’s Collegium Pharmaceutical COLL Stock Holding History

Zurich Cantonal Bank’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,470
Closed -$531K – 2787
2025
Q4 		$531K Buy
+11,470
New +$480K ﹤0.01% 1753

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Zurich Cantonal Bank's COLL Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Collegium Pharmaceutical (COLL) in Q1 2026: 13,657 shares worth $452K. The stake represents ﹤0.01% of the portfolio and ranks #1888 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in COLL as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in COLL in Q4 2017 and has held it in 33 quarters since. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Zurich Cantonal Bank held 13,657 shares of Collegium Pharmaceutical worth $452K as of Q1 2026.
  • Collegium Pharmaceutical was a new Zurich Cantonal Bank position in Q1 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1888 holding.
  • Zurich Cantonal Bank first reported a position in Collegium Pharmaceutical in Q4 2017 and has held it in 33 quarters since.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.